Atossa Therapeutics Inc (ATOS)
1.50
+0.10
(+7.14%)
USD |
NASDAQ |
Sep 27, 16:00
1.49
-0.01
(-0.67%)
After-Hours: 20:00
Atossa Therapeutics Cash from Financing (Quarterly): 0.10M for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.10M |
| March 31, 2024 | 0.204M |
| December 31, 2023 | 0.00 |
| September 30, 2023 | -1.475M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.001M |
| September 30, 2021 | 0.679M |
| June 30, 2021 | 10.20M |
| March 31, 2021 | 102.43M |
| December 31, 2020 | 33.88M |
| September 30, 2020 | 4.324M |
| June 30, 2020 | 0.3476M |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 11.34M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 12.29M |
| Date | Value |
|---|---|
| March 31, 2018 | |
| December 31, 2017 | 6.166M |
| September 30, 2017 | 0.7453M |
| June 30, 2017 | 3.872M |
| March 31, 2017 | |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 2.562M |
| June 30, 2016 | -0.0326M |
| March 31, 2016 | 2.166M |
| December 31, 2015 | 0.0076M |
| September 30, 2015 | -0.0539M |
| June 30, 2015 | 5.211M |
| March 31, 2015 | 4.292M |
| December 31, 2014 | -0.0985M |
| September 30, 2014 | 0.15M |
| June 30, 2014 | 0.05M |
| March 31, 2014 | 12.96M |
| December 31, 2013 | 1.386M |
| September 30, 2013 | 8.303M |
| June 30, 2013 | 3.245M |
| March 31, 2013 | 1.003M |
| December 31, 2012 | 3.374M |
| September 30, 2012 | 0.4816M |
| June 30, 2012 | 0.00 |
| March 31, 2012 | -0.0062M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.475M
Minimum
Sep 2023
102.43M
Maximum
Mar 2021
7.534M
Average
--
Median
Sep 2019
Cash from Financing (Quarterly) Benchmarks
| Hologic Inc | -103.80M |
| Perspective Therapeutics Inc | 122.08M |
| Spectral AI Inc | 2.082M |
| Electromed Inc | -0.075M |
| Xtant Medical Holdings Inc | 6.434M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.531M |
| Cash from Investing (Quarterly) | -0.003M |
| Free Cash Flow | -18.69M |
| Free Cash Flow Per Share (Quarterly) | -0.0361 |
| Free Cash Flow Yield | -9.93% |